Role of atrial natriuretic peptide in the suppression of lysophosphatydic acid-induced rat aortic smooth muscle (RASM) cell growth

Molecular and Cellular Biochemistry

Volumn 272, Issue 1-2, 2005, Pages 19-28

  Baldini, P M ^a   De Vito, P ^a   D'aquilio, F ^a   Vismara, D ^a   Zalfa, F ^a,b   Bagni, C ^a,b   Fiaccavento, R ^a   Di Nardo, P ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

Atrial natriuretic peptide; Lysophosphatidic acid; Phosphatidylinositol 3 kinase; Reactive oxygen species

Indexed keywords

8 BROMO CYCLIC GMP; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; DNA; LYSOPHOSPHATIDIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; NATRIURETIC PEPTIDE TYPE C; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P42; PROTEIN P44; REACTIVE OXYGEN METABOLITE; WORTMANNIN;

ANIMAL CELL; ARTICLE; CARDIOVASCULAR RESPONSE; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HOMEOSTASIS; MALE; MITOSIS INHIBITION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; THORACIC AORTA;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ANIMALS; AORTA; ATRIAL NATRIURETIC FACTOR; CELLS, CULTURED; DNA REPLICATION; ENZYME ACTIVATION; LYSOPHOSPHOLIPIDS; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; RECEPTORS, LYSOPHOSPHATIDIC ACID; SIGNAL TRANSDUCTION;

EID: 20944435666     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11010-005-4779-0     Document Type: Article

References (41)

1. Anand-Srivastava MB, Trachte GJ: Atrial natriuretic factor receptors and signal transduction. Pharmacol Rev 454: 455-497, 1993
2. Cao L, Gardner DG: Natriuretic peptides inhibit DNA synthesis in cardiac fibroblast. Hypertension 25:227-234, 1995 1:CAS:528:DyaK2MXkvF2gtL8%3D
3. Rashed HM, Sun H, Patel TB: Atrial natriuretic peptide inhibits growth of hepatoblastoma HepG2 cells by means of activation of clearance receptors. Hepatology 17: 677-684, 1993 1:CAS:528:DyaK3sXkvVOisLs%3D
4. Cahill PA, Hassid A: Clearance receptor binding atrial natriuretic peptide inhibit mitogenesis and proliferation of rat aortic smooth muscle cells. Biochem Biophys Res Commun 179: 1606-1613, 1991 10.1016/ 0006-291X(91)91758-5
5. Zannetti A, Luly P, Musanti R, Baldini PM: Phosphatidylinositol-and phosphatidylcholine-dependent phospholipase C are involved in the mechanism of action of atrial natriuretic factor in cultured rat aortic smooth muscle cells. J Cell Physiol 170: 272-278, 1997 10.1002/ (SICI)1097-4652(199703)170:3<272::AID-JCP8>3.0.CO;2-L
6. Baldini PM, De Vito P, Fraziano M, Mattioli P, Luly P, Di Nardo P: Atrial Natriuretic Factor inhibits mitogen-induced growth in rat aortic smooth muscle cells. J Cell Physiol 193: 103-109, 2002 10.1002/jcp.10155
7. Prins BA, Weber MJ, Hu RM, Pedram A, Daniels M, Levin ER: Atrial natriuretic peptide inhibits mitogen-activated protein kinase through the clearance receptor. J Biol Chem 271: 14156-14162, 1996 10.1074/ jbc.271.24.14156
8. Levin ER, Frank HJL: Natriuretic peptides inhibit rat astroglial proliferation: Mediation by C receptor. Am J Physiol 261: 453-457, 1991
9. Huwiler A, Kolter T, Pfelshifter J, Sandhoff K: Physiology and pathophysiology of sphingolipid metabolism and signaling. Biochim Biophys Acta 1485: 63-99, 2000 1:CAS:528:DC%2BD3cXjs1Cntbg%3D
10. Eichholtz T, Jalink K, Fahrefort I, Moolenaar WH: The bioactive phospholipids lysophosphatidic acid is released from activated platelets. Biochem J 291: 677-680, 1993 1:CAS:528:DyaK3sXisFaju7s%3D
11. Anliker B, Chun J: Lysophospholipid G protein-coupled receptors. J Biol Chem 279: 20555-20558, 2004 10.1074/jbc.R400013200
12. Tigyi G, Dyer DL, Miledi R: Lysophosphatidic acid possesses dual action in cell proliferation. Proc Natl Acad Sci USA 91: 1908-1912, 1994 1:CAS:528:DyaK2cXitFekt7w%3D
13. Jalink K, Hordijk PL, Moolenaar WH: Growth factor-like effects of lysophosphatidic acid, a novel lipid mediator. Biophys Biochim Acta 1198: 185-196, 1994 1:CAS:528:DyaK2MXjtVSnsbw%3D
14. Inoue CN, Ko YH, Guggino WB, Forster HG, Epstein M: Lysophosphatidic acid and platelet-derived growth synergistically stimulate growth of cultured rat mesangial cells. Proc Soc Exp Biol Med 216: 370-379, 1997 1:CAS:528:DyaK2sXnvV2ntr0%3D
15. Xu YJ, Rathi SS, Chapman DC, Arneja AS, Dhalla NS: Mechanisms of lysophosphatidic acid-induced DNA synthesis in vascular smooth muscle cells. J Cardiovasc Pharmacol 41: 381-387, 2003 10.1097/ 00005344-200303000-00006
16. Moolenaar WH: Lysophosphatidic acid, a multifunctional phospholipid messenger. J Biol Chem 270: 12949-12952, 1995 1:CAS:528:DyaK2MXmtV2itrw%3D
17. Yart A, Chap H, Raynal P: Phosphoinositide 3-kinases in lysophosphatidic acid signalling: Regulation and cross-talk with Ras/mitogen-activated protein kinase pathway. Biochim Biophys Acta 582: 107-111, 2002
18. 2. Mol Cell Biol 24: 4384-4394, 2004 10.1128/MCB.24.10.4384-4394.2004
19. Chen Q, Olashaw N, Wu J: Partecipation of reactive oxygen species in the lysophosphatidic acid-stimulated mitogen-activated protein kinase kinase activation pathway. J Biol Chem 270: 28499-28502, 1995 10.1074/ jbc.270.48.28499
20. Hayashi K, Takahashi M, Nishida W, Yoshida K, Ohkawa Y, Kitabatake A, Aoki J, Arai H, Sobue K: Phenotypic modulation of vascular smooth muscle cells induced by unsaturated lysophosphatidic acids. Circ Res 89: 251-258, 2001 1:CAS:528:DC%2BD3MXmt1ClsL4%3D
21. Kunsch C, Medford RM: Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 85: 753-766, 1999 1:CAS:528:DyaK1MXms1Kqsr4%3D
22. Ross RJ: The smooth muscle cell II. Growth of muscle in culture and formation of elastic fibers. J Cell Physiol 50: 171-186, 1971
23. J Sambrook E F Fritsch T Maniatis 1989 Laboratory Manual. Molecular Cloning A Second Edition Cold Spring Harbor Laboratory Press New York
24. Baldini PM, De Vito P, Martino A, Fraziano M, Grimaldi C, Luly P, Zalfa F, Colizzi V: Differential sensitivity of human monocytes and macrophages to ANP: A role of intracellular pH on reactive oxygen species production through the phospholipases involvement. J Leukoc Biol 73: 502-510, 2003 10.1189/jlb.0702377
25. Zalfa F, Giorgi M, Primerano B, Moro A, Di Penta A, Reis S, Oostra B, Bagni C: The fragile X sindrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNA at synapses. Cell 112: 317-327, 2003 10.1016/S0092-8674(03)00079-5
26. Shen H, Shi CY, Shen Y, Ong CN: Detection of elevated reactive oxygen species level in cultured rat hepatocytes treated with aflatoxin B1. Free Rad Biol Med 21: 139-146, 1996 10.1016/0891-5849(96)00019-6
27. Krause U, Rider MH, Hue L: Protein kinase signalling pathway triggered by cell swelling and involved in the activation of glycogen synthase and acetyl-CoA carboxylase in isolated rat hepatocytes. J Biol Chem 271: 16668-16673, 1996 10.1074/jbc.271.28.16668
28. Lowry OH, Rosebrough NJ, Farr AL, Randal RJ: Protein measurement with the Folin phenol reagent. J Biol Chem193: 265-268, 1951 1:CAS:528:DyaG38XhsVyrsw%3D%3D
29. Ye X, Ishii I, Kingsbury MA, Chun J: Lysophosphatidic acid as a novel cell survival/apoptitic factor. Biochim Biophys Acta 1585: 108-113, 2002 1:CAS:528:DC%2BD3sXivVOqsQ%3D%3D
30. Silberbach M, Roberts CT Jr: Natriuretic peptide signalling molecular and cellular pathways to growth regulation. Cell Signal 13: 221-231, 2001 10.1016/S0898-6568(01)00139-5
31. Rivard A, Andreas V: Vascular smooth muscle cells proliferation in the pathogenesis of atherosclerosis cardiovascular disease. Histol Histopathol 15: 557-571, 2000 1:CAS:528:DC%2BD3cXktVens78%3D
32. Siess W: Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate. Biochim Biophys Acta 1582: 204-215, 2002 1:CAS:528:DC%2BD38XksF2htLo%3D
33. Schmitz U, Thommes K, Beier I, Vetter H: Lysophosphatidic acid stimulates p21-activated kinase in vascular smooth muscle cells. Biochem Biophys Res Commun 291: 687-691, 2002 10.1006/bbrc.2002.6493
34. ++ of human adult vascular smooth muscle cells in culture. Thromb Res 94: 317-326, 1999 10.1016/S0049-3848(99)00004-3
35. Bilzer M, Jaeschke H, Vollmar AM, Paumgartner C, Gerbers AL: Prevention of Kupffer cell-induced oxidant injury in rat liver by atrial natriuretic peptide. Am J Physiol 276: 1137-1144, 1999
36. 2+ changes in rat aortic smooth muscle cells. The role of atrial natriuretic peptide. Mol Cell Biochem 252: 353-362, 2003 10.1023/A:1025508828271
37. Carini R, De Cesaris MG, Splendore R, Domenicotti C, Nitti MP, Pronzato MA, Albano E: Mechanism of hepatocyte protection against hypoxic injury by atrial natriuretic peptide. Hepatology 37: 277-285, 2003 10.1053/ jhep.2003.50033
38. Cahill PA, Hassid A: Differential antimitogenic effectiveness of atrial natriuretic peptides in primary vs. subcultured rat aortic smooth muscle cells: Relationship to expression of ANF-C receptors. J Cell Physiol 154: 28-38, 1993 10.1002/jcp.1041540105
39. Cao L, Wu J, Gardner DG: Atrial natriuretic peptide supresses the transcription of its guanylyl cyclase- linked receptor. J Biol Chem. 270: 24891-24897, 1995 1:CAS:528:DyaK2MXovFWms7g%3D
40. Koyasu S: The role of PI3K in immune cells. Nature Immunol 4: 313-319, 2003 10.1038/ni0403-313
41. Abbey ES, Potter LR: Lysophosphatidic acid inhibits C-type, natriuretic peptide activation of guanylyl cyclase-B. Endocrinol 144: 240-246, 2003 10.1210/en.2002-220702